Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy
Author:
Funder
NIH
AIST
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference97 articles.
1. Nanotechnological carriers for cancer chemotherapy: the state of the art;Estanqueiro;Colloids Surf. B: Biointerfaces,2015
2. Nanoparticle drug formulations for cancer diagnosis and treatment;Poon;Crit. Rev. Oncog.,2014
3. Multifunctional nanoparticles: recent progress in cancer therapeutics;Seeta Rama Raju;Chem. Commun. (Camb.),2015
4. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting;Maeda;Adv. Enzym. Regul.,2001
5. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery;Liong;ACS Nano,2008
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ternary Cu2MX4 (CMX)-based nanoarchitectonics: Chemistry, synthesis, and biomedical applications;Coordination Chemistry Reviews;2024-11
2. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16
3. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12
4. Development and characterization of magnetic-based biodegradable periodic mesoporous organosilica nanoparticles for enhanced biomedical applications;Journal of Industrial and Engineering Chemistry;2024-07
5. Tuning the Physical State of Aripiprazole by Mesoporous Silica;Molecular Pharmaceutics;2024-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3